Nova Leap HealthNVLPF 50 Current Ratio is 1.02 as of Mar. 2026, which is at its 10-year median of 1.02. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.19 (Fairly Valued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Nova Leap Health ranks worse than 72.33% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Nova Leap Health's current ratio for the quarter that ended in Mar. 2026 was 1.02.
Nova Leap Health has a current ratio of 1.02. It generally indicates good short-term financial strength.
The historical rank and industry rank for Nova Leap Health's Current Ratio or its related term are showing as below:
NVLPF'
s Current Ratio Range Over the Past 10 Years
Min: 0.38 Med: 1.02 Max: 7.42
Current: 1.02
During the past 10 years, Nova Leap Health's highest Current Ratio was 7.42. The lowest was 0.38. And the median was 1.02.
NVLPF's Current Ratio is ranked worse than 72.33% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs NVLPF: 1.02
Nova Leap Health (OTCPK:NVLPF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Nova Leap Health Current Ratio Related Terms
Nova Leap Health Current Ratio Historical Data
* Premium members only.
The historical data trend for Nova Leap Health's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nova Leap Health's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Leap Health Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Current Ratio distribution charts can be found below:
* The bar in red indicates where Nova Leap Health's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova Leap Health (NVLPF) has a Current Ratio of 1.02 as of Mar. 2026. This is near median its historical median of 1.02. Over the past decade, Nova Leap Health's Current Ratio has ranged from 0.38 to 7.42. According to the industry distribution chart, Nova Leap Health ranks #494 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 72.3%.
Is Nova Leap Health's Current Ratio too high?
Nova Leap Health's current Current Ratio of 1.02 is near median its 10-year median of 1.02. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 7.42. The Healthcare Providers & Services industry median Current Ratio is 1.47. Nova Leap Health's value of 1.02 is 30.6% below this industry median. Based on the distribution chart, Nova Leap Health ranks #494 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #494 out of 683 companies for Current Ratio. This places Nova Leap Health in the lower half of its industry. The industry median Current Ratio is 1.47. Nova Leap Health's value of 1.02 is 30.6% below this benchmark. Historically, Nova Leap Health's own Current Ratio has ranged from 0.38 to 7.42 over the past decade. While the company's 10-year median is 1.02 vs. the industry median of 1.47, Nova Leap Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current Current Ratio of 1.02 is 30.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current Current Ratio is 1.02, which is near median its own 10-year median of 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Fairly Valued. The stock's GF Value™ is $0.19, compared to a current price of $0.25 — trading 29.7% above its estimated fair value. The current Current Ratio is 1.02, which is near median its 10-year median of 1.02 and 30.6% below the Healthcare Providers & Services industry median of 1.47. Nova Leap Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current Current Ratio is 1.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova Leap Health (NVLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued.
The current stock price of $0.25 is trading 29.7% above its estimated GF Value™ of $0.19.
GuruFocus considers Nova Leap Health to be Fairly Valued.
Key valuation signals for NVLPF:
Current Ratio: 1.02 (near median its 10-year median of 1.02)
GF Value™: $0.19 vs. price of $0.25 (29.7% above fair value)
Industry Position: 30.6% below the Healthcare Providers & Services median (#494 of 683)
No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score
Get the complete analysis for NVLPF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVLPF has been successfully added to your 
